Clinical Trials on HER2-mutant Non-Small Cell Lung Cancer in United Kingdom
Total 4093 results
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Puma Biotechnology, Inc.CompletedHER2-mutant Non-Small Cell Lung CancerUnited States, France
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
University Hospital Southampton NHS Foundation...Royal Bournemouth and Christchurch Hospitals NHS Foundation TrustUnknownNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited Kingdom
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Royal Marsden NHS Foundation TrustBristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited Kingdom
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon Small Cell Lung CancerUnited Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Silverback TherapeuticsTerminatedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Colorectal Cancer | HER2-expressing Non-small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-small-cell Lung CancerUnited Kingdom
-
University of HullHull University Teaching Hospitals NHS TrustWithdrawnLung Cancer | Non-small Cell Lung CancerUnited Kingdom
-
Oxford University Hospitals NHS TrustNational Institute for Health Research, United KingdomCompleted
-
Royal Marsden NHS Foundation TrustUnknownNon-small Cell Lung CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Merck Serono GmbH, GermanyRecruitingNon Small Cell Lung Cancer | Advanced CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
The Christie NHS Foundation TrustAstraZeneca; University of ManchesterCompleted
-
University College, LondonCancer Research UKRecruitingSmall Cell Lung Cancer | Lung Cancer, Non-small Cell | Pleural MesotheliomaUnited Kingdom
-
Cancer Research UKCompletedAdvanced Non-small Cell Lung CancerUnited Kingdom
-
Liverpool Heart and Chest Hospital NHS Foundation...WithdrawnNon Small Cell Lung Cancer | Aspirin | SurvivalUnited Kingdom
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
Achilles Therapeutics UK LimitedTerminatedMelanoma | Advanced Non Small Cell Lung CancerUnited Kingdom
-
Agenus Inc.CompletedLung Cancer | Non-Small-Cell Lung Carcinoma | Pulmonary CancerUnited Kingdom
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung Cancer Metastatic | Nonsquamous Non-Small Cell Neoplasm of Lung | Non-Small Cell Lung Cancer Stage IIIBUnited Kingdom, Sweden
-
Lisette NixonCompletedLocally Advanced Non-small Cell Lung CancerUnited Kingdom
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
Prof Corinne Faivre-FinnRoyal Marsden NHS Foundation Trust; The Leeds Teaching Hospitals NHS Trust; Cambridge... and other collaboratorsCompletedNon Small Cell Lung CancerUnited Kingdom
-
Cancer Research UKBicycle TherapeuticsCompletedNon-Small Cell Lung Cancer | Advanced Solid Tumours | Oesophageal Cancer | Non-Small Cell Lung SarcomaUnited Kingdom
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
University of OxfordCancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaboratorsCompletedLocally Advanced Non-Small Cell Lung CancerUnited Kingdom
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, United Kingdom
-
Clovis Oncology, Inc.TerminatedLung Cancer | Solid Tumor | Non-small-cell Lung CancerUnited States, United Kingdom
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited Kingdom
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom